Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
11/2007
11/08/2007CA2649811A1 Triazoloquinazolinone derivatives as inhibitors of checkpoint kinases
11/08/2007CA2648139A1 Diaryl thiohydantoin compounds and their use in the treatment of hyperproliferative disorders
11/08/2007CA2648077A1 Parenteral low dose type 1 interferons for bladder cancer
11/08/2007CA2647277A1 Method for using boc/cdo to modulate hedgehog signaling
11/08/2007CA2646048A1 Compositions and methods of use for antibodies of c-met
11/08/2007CA2638133A1 Anti-ephrinb2 antibodies and methods using same
11/07/2007EP1852432A1 Nitrogenous heterocyclic compound and medicinal use thereof
11/07/2007EP1852126A2 Vaccine for modulating between T1 and T2 immune responses
11/07/2007EP1852123A2 Activation and inhibition of the immune system
11/07/2007EP1852121A2 Lipid analogs for treating viral infections
11/07/2007EP1852112A1 Anti-tumor agent
11/07/2007EP1852107A1 Magnetic nanoparticles compositions and uses thereof
11/07/2007EP1851251A2 Monoclonal antibodies against prostate specific membrane antigen (psma) lacking in fucosyl residues
11/07/2007EP1851249A2 Cd20 antibody variants and uses thereof
11/07/2007EP1851230A1 Tetrahydropyridothiophenes as antripoliferative agents for the treatment of cancer
11/07/2007EP1851229A1 Tetrahydropyridothiophenes for the treatment of proliferative diseases such as cancer
11/07/2007EP1851228A1 Pyrimidothiophene compounds having hsp90 inhibitory activity
11/07/2007EP1851219A1 Fused heterocyclic compounds useful as inhibitors of histone deacetylase
11/07/2007EP1851217A1 Substituted pyrido(2,3-d)pyrimidine derivatives useful as medicines for the treatment of autoimmune disorders
11/07/2007EP1851200A2 Dimeric iap inhibitors
11/07/2007EP1851198A1 Substituted pyrroles, compositions containing same, method for making same and use thereof
11/07/2007EP1850874A2 Extending time to disease progression or survival in cancer patients using a her dimerization inhibitor
11/07/2007EP1850862A2 Methods of treating disease with glycosylated interferon
11/07/2007EP1850860A2 Prostate stem cell antigen vaccines and uses thereof
11/07/2007EP1850851A2 Methods for treating cancer and other pathological proliferating disorders by inhibiting mitosis using pyrrolo[2,3-d]pyrimidines
11/07/2007EP1850848A1 Tetracyclic sulfonamide compounds and methods of use thereof
11/07/2007EP1850830A1 Method for production of a preparation of a solid dmso-containing silicone oil emulsion for the binding of reactive oxygen compounds in human and animal bodies
11/07/2007EP1850663A2 Use of minoxidil sulfate as an anti-tumor drug
11/07/2007EP1664033B1 9,10-alpha,alpha-oh-taxane analogs and methods for production the reof
11/07/2007EP1651684B1 Etherified carbamate functional copolymers of isobutylene type monomers, and their use in curable compositions
11/07/2007EP1543008B1 Imidazopyrazines as cyclin dependent kinase inhibitors
11/07/2007EP1520175B1 Oncolytic viruses as phenotyping agents for neoplasms
11/07/2007EP1361225B1 Compounds substituted with bicyclic amino groups
11/07/2007EP1317276B1 Therapeutic use of a recombinant erythropoietin omega having high activity and reduced side effects
11/07/2007EP1257281B1 Nucleoside analogs with carboxamidine modified monocyclic base
11/07/2007EP1192151B1 Anilinoquinazolines as protein tyrosine kinase inhibitors
11/07/2007CN101068836A Anti-glypican 3 antibody having modified sugar chain
11/07/2007CN101068826A Potent LNA oligonucleotides for the inhibition of HIF-1A expression
11/07/2007CN101068805A Novel phenylaminopyrimidine derivatives as inhibitors of BCR-ABL kinase
11/07/2007CN101068569A Anti-cancer virus desensitization method
11/07/2007CN101068558A Improved anti-cancer treatment
11/07/2007CN101067151A Primer, segment and method for identifying sex of air potato
11/07/2007CN101067146A Biological extraction process of main chemical components in licorice
11/07/2007CN101067120A Fecal enterococcus CMS-II001 and its application
11/07/2007CN101067006A Low molecular Brazil mushroom polysaccharide and its prepn process and application in antagonizing tumor metastasis
11/07/2007CN101067004A Moxa leaf polysaccharide and its use
11/07/2007CN101067001A Human glycosyl-phosphatidyl inositol-CD80 fusion protein
11/07/2007CN101066997A Human antibodies that bind human IL-12 and methods for producing
11/07/2007CN101066993A Recombinant staphylococcus aureus enterotoxin M and its prepn and application
11/07/2007CN101066991A Antigenic determinant polypeptide of human tumor-testis antigen HCA587 and its application
11/07/2007CN101066964A Juglone possessing anti cancer activity and its prepn
11/07/2007CN101066963A Polysubstituted flavanone derivative and its prepn and application
11/07/2007CN101066962A Synthetic methods for polyphenols
11/07/2007CN101066961A Flavone derivative and its prepn and use
11/07/2007CN101066956A Polysubstituted aurone derivative and its prepn and use
11/07/2007CN101066916A Korean pine pinecone extract and its application and extraction process
11/07/2007CN101066465A Antitumor use of antisense thionucleotide
11/07/2007CN101066462A Application of cytoplasm targeting administration system capable of reversing tumor cell resistance
11/07/2007CN101066461A Application of cell nucleus targeting chitosan-fatty acid graft as medicine carrier micelle
11/07/2007CN101066458A Application of cell nucleus targeting administration system capable of reversing tumor cell resistance
11/07/2007CN101066454A Solid tumor treating medicine composition
11/07/2007CN101066453A Solid tumor treating medicine composition
11/07/2007CN101066452A Solid tumor treating medicine composition containing
11/07/2007CN101066451A Solid tumor treating medicine composition containing dicloethamine
11/07/2007CN101066439A Wind dispelling and obstruction eliminating capsule and its prepn
11/07/2007CN101066437A Quality control method for compound cantharis oral liquid
11/07/2007CN101066390A Medicine for treating mammary cancer and mastoproliferation
11/07/2007CN101066283A Medicine for treating women's inflammation
11/07/2007CN101066273A Antitumor medicine containing betulic acid derivative
11/07/2007CN101066265A Application of BM-Cyclinl in medicine for reversing tumor resistance
11/07/2007CN101066261A Application of dryopteris fragrans phloroglucinol extract
11/07/2007CN101066260A Coenzyme Q10 emulsion and its freeze dried prepn and their prepn process
11/07/2007CN101066255A Coated ubenimex table
11/07/2007CN101066122A Liquid detergent
11/07/2007CN101066081A Agrimonia herb green tea
11/07/2007CN100347299C GATA-2 mutator as one of leukemia rapid change major genes and its use
11/07/2007CN100347196C Ganodema tsugae-proteoglycan and its preparing method and use
11/07/2007CN100347187C Process for preparing anticencer active protein of thick muzzle syngnathus
11/07/2007CN100347176C Novel dithiolopyrrolones with therapeutic activity
11/07/2007CN100347170C Azabicyclo-octane and nonane derivatives with DPP-IV inhibiting activity
11/07/2007CN100347169C 喹唑啉衍生物 Quinazoline derivatives
11/07/2007CN100347163C Cyclohexenone analog bicyclo (condensed ring) compound and its preparation method and uses
11/07/2007CN100347162C N－苯基－2－嘧啶胺衍生物 N- phenyl-2-pyrimidine-amine derivative
11/07/2007CN100347152C Benzamide or phenylacetamide derivatives useful as thyroid receptor ligands
11/07/2007CN100346833C Formulation for inwardly transferring nucleic acids into eucaryotic cells
11/07/2007CN100346830C Medicinal composition for treating B cell lymph tumour
11/07/2007CN100346829C Adjuvant compsn comprising immunostimulatory oligonucleotide and tocol
11/07/2007CN100346796C Phy siologically active substance EEM-S originating in mushrooms, process for producing same and drugs
11/07/2007CN100346791C Controlled and released preparation of kurarinone detained in stomach
11/07/2007CN100346786C Substituted benzimidazole compounds and their use for the treatment of cancer
11/07/2007CN100346784C Pharmaceutical formulations of antineoplastic agents,in particular temozolomide, processes of making and using the same
11/07/2007CN100346772C Devices for delivery of drugs having antiprogestinic properties
11/06/2007USRE39916 Compounds that modulate PPAR activity and methods for their preparation
11/06/2007US7291732 Isomeric fused pyrrolocarbazoles and isoindolones
11/06/2007US7291709 LSR (Lipolysis Stimulated Receptor); for the prevention and/or treatment of pathologies and/or of pathogeneses such as obesity and anorexia, hyperlipidemias, atherosclerosis, diabetes, hypertension
11/06/2007US7291650 Breast cancer ; therapy containing plant extracts
11/06/2007US7291637 4,7-Methano--, ethano-, oxy- or thio- indazol-3-ones or benzisothiazol-3-ones in which the S is mono- or dioxygenated, e.g., 3a,4,7,7a-tetrahydro-4,7-methano-1,2-benzisothiazol-3(2H)-one-1,1-dioxide; treatment of diseases such as cancer and immune disorders
11/06/2007US7291635 Protein tyrosine phosphatase 1B inhibitors alone or incombination with other antidiabetic, antilipemic, anticholesterol or hypotensive agents
11/06/2007US7291634 N-substituted-benzyl-N-(hydroxyaminocarbonylmethyl)cycloalkyl(alk)oxybenzenesulfonamides, e.g., 2-[(cyclopropylmethoxy-benzenesulfonyl)-(4-[1,2,3]triazol-1-yl-benzyl)-amino]-N-hydroxy-acetamide; treating diseases mediated by matrix-degrading metalloproteinases, in particular hyperproliferative diseases
11/06/2007US7291630 Azaindoles as inhibitors of c-Jun N-terminal kinases
1 ... 1025 1026 1027 1028 1029 1030 1031 1032 1033 1034 1035 1036 1037 1038 1039 1040 1041 1042 1043 1044 1045 ... 2211